Ritholtz Wealth Management Buys 1,996 Shares of HCA Healthcare, Inc. $HCA

Ritholtz Wealth Management increased its position in HCA Healthcare, Inc. (NYSE:HCA) by 16.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,972 shares of the company’s stock after acquiring an additional 1,996 shares during the quarter. Ritholtz Wealth Management’s holdings in HCA Healthcare were worth $6,612,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HCA. Palisade Asset Management LLC purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $26,000. Holos Integrated Wealth LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $29,000. Ares Financial Consulting LLC bought a new position in HCA Healthcare in the fourth quarter valued at $31,000. JPL Wealth Management LLC bought a new stake in HCA Healthcare during the third quarter worth about $33,000. Finally, Aventura Private Wealth LLC bought a new position in HCA Healthcare during the fourth quarter valued at approximately $34,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 0.4%

Shares of NYSE:HCA opened at $388.38 on Thursday. The company has a market cap of $86.16 billion, a price-to-earnings ratio of 13.36, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The company has a 50-day moving average price of $412.73 and a 200-day moving average price of $466.54.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the prior year, the firm earned $6.45 EPS. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA was highlighted as a top value stock for long-term investors, reinforcing the view that the shares may be attractive based on fundamentals and valuation. Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
• Positive Sentiment: TriStar, part of HCA, received a certificate of need to build a freestanding emergency room in Lebanon, which supports continued facility expansion and local growth. TriStar gains certificate of need to build freestanding ER in Lebanon
• Positive Sentiment: HCA Healthcare Foundation awarded $2.1 million in grants to 89 Middle Tennessee nonprofits, reinforcing community ties and brand goodwill in a core market. 89 Middle Tennessee nonprofits awarded $2.1M in grants by HCA Healthcare Foundation
• Neutral Sentiment: HCA sold 31 home health and hospice agencies, and DAI is acquiring 24 home health agencies from HCA, suggesting ongoing portfolio reshaping but not an obviously major earnings catalyst. HCA sells 31 home health, hospice agencies DAI To Acquire 24 Home Health Agencies From HCA, ‘Doubling Down’ On Care In The Home
• Neutral Sentiment: Coverage on the Frist family and HCA’s history, along with the naming of a new hospital CEO and a healthcare CEO pay list, is largely informational and unlikely to move the stock by itself. Frist family letter reveals the values that built HCA Healthcare by Dr. Thomas Frist Sr. HCA HealthONE names CEO of 2 Denver hospitals 23 highest-paid healthcare CEOs: Wall Street Journal
• Negative Sentiment: HCA’s chief clinical officer is set to exit after four years, creating some leadership turnover at the company. HCA’s chief clinical officer to exit after 4 years

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. KeyCorp lowered their price objective on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. JPMorgan Chase & Co. lowered their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. Argus reduced their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Jefferies Financial Group restated a “buy” rating and set a $525.00 target price on shares of HCA Healthcare in a report on Friday, April 24th. Finally, Stephens decreased their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Fifteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $503.00.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.